- Record: found
- Abstract: found
- Article: not found
Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The objective of the study was to assess the efficacy and safety of four fixed doses of nateglinide compared with placebo in the treatment of patients with type 2 diabetes with focus on the prandial state.